Overview

* Albemarle Q2 net sales of $1.3 bln beat analyst expectations, per LSEG data

* Adjusted EPS for Q2 beats consensus, per LSEG data

* Co reduces full-year 2025 capital expenditure outlook to $650-$700 mln

Outlook

* Albemarle expects full-year 2025 net sales of $4.9 - $5.2 bln

* Company projects 2025 adjusted EBITDA between $0.8 - $1.0 bln

* Albemarle reduces 2025 capital expenditure outlook to $650 - $700 mln

* Company anticipates positive free cash flow for 2025

Result Drivers

* ENERGY STORAGE VOLUMES - Record production from integrated conversion network led to 15% volume growth in Energy Storage

* SPECIALTIES DEMAND - Higher demand and productivity initiatives increased Specialties adjusted EBITDA by 34.7%

* COST SAVINGS - Improved fixed cost absorption and ongoing cost savings supported adjusted EBITDA despite lower lithium pricing

Key Details

Metric Beat/Mis Actual Consensu

s s

Estimate

Q2 Net Beat $1.33 $1.22

sales bln bln (18

Analysts

)

Q2 Beat $0.11 -$0.82

Adjusted (20

EPS Analysts

)

Q2 EPS -$0.16

Q2 Beat $336.50 $195.70

Adjusted mln mln (18

EBITDA Analysts

)

Analyst Coverage

* The current average analyst rating on the shares is "hold" and the breakdown of recommendations is 9 "strong buy" or "buy", 15 "hold" and 4 "sell" or "strong sell"

* The average consensus recommendation for the specialty chemicals peer group is "buy."

* Wall Street's median 12-month price target for Albemarle Corp ( ALB ) is $75.50, about 5.2% above its July 29 closing price of $71.60

Press Release:

(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)